TY - CHAP
T1 - Nano/microformulations for Bacteriophage Delivery
AU - Cortés Garmendia, Pilar
AU - Cano-Sarabia, Mary
AU - Colom, Joan
AU - Otero, Jennifer
AU - Maspoch, Daniel
AU - Llagostera, Montserrat
N1 - Publisher Copyright:
© The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2024.
PY - 2024
Y1 - 2024
N2 - Encapsulation methodologies allow the protection of bacteriophages for overcoming critical environmental conditions. Moreover, they improve the stability and the controlled delivery of bacteriophages which is of great innovative value in bacteriophage therapy. Here, two different encapsulation methodologies of bacteriophages are described using two biocompatible materials: a lipid cationic mixture and a combination of alginate with the antacid CaCO3. To perform bacteriophage encapsulation is necessary to dispose of a purified and highly concentrated lysate (around 1010 to 1011 pfu/mL) and a specific equipment. Both methodologies have been successfully applied for encapsulating Salmonella bacteriophages with different morphologies. Also, the material employed does not modify the antibacterial action of bacteriophages. Moreover, both technologies can be adapted to any bacteriophage and possibly to any delivery route for bacteriophage therapy.
AB - Encapsulation methodologies allow the protection of bacteriophages for overcoming critical environmental conditions. Moreover, they improve the stability and the controlled delivery of bacteriophages which is of great innovative value in bacteriophage therapy. Here, two different encapsulation methodologies of bacteriophages are described using two biocompatible materials: a lipid cationic mixture and a combination of alginate with the antacid CaCO3. To perform bacteriophage encapsulation is necessary to dispose of a purified and highly concentrated lysate (around 1010 to 1011 pfu/mL) and a specific equipment. Both methodologies have been successfully applied for encapsulating Salmonella bacteriophages with different morphologies. Also, the material employed does not modify the antibacterial action of bacteriophages. Moreover, both technologies can be adapted to any bacteriophage and possibly to any delivery route for bacteriophage therapy.
KW - Alginate
KW - Bacteriophages
KW - Liposomes
KW - Microparticles
KW - Nanoparticles
UR - http://www.scopus.com/inward/record.url?scp=85179645634&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/865ad031-ac1d-3c43-a717-7b769ba3fa79/
U2 - 10.1007/978-1-0716-3523-0_7
DO - 10.1007/978-1-0716-3523-0_7
M3 - Chapter
C2 - 38066365
SN - 9781071635223
SN - 9781071635230
VL - 2734
T3 - Methods in Molecular Biology
SP - 117
EP - 130
BT - Methods in Molecular Biology
ER -